Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone

• Main Authors: Carlos K. H. Wong (Author), Kristy T. K. Lau (Author), Ivan C. H. Au (Author), Xi Xiong (Author), Matthew S. H. Chung (Author), Belle Y. C. Leung (Author), Eric H. Y. Lau (Author), Benjamin J. Cowling (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: This retrospective cohort study aims to explore head-to-head clinical outcomes and complications associated with tocilizumab or baricitinib initiation among hospitalized COVID-19 patients receiving dexamethasone.Methods: Among 10,445 COVID-19 patients hospitalized between January 21st 20...